TRexBio
Pre-clinicalTRexBio is creating purpose-built biologics aimed at restoring immune balance in autoimmune and inflammatory diseases. By addressing the disease where it presents, in the tissue, our goal is to quiet the inflammatory process and restore tissue homeostasis.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $69M
About
TRexBio is creating purpose-built biologics aimed at restoring immune balance in autoimmune and inflammatory diseases. By addressing the disease where it presents, in the tissue, our goal is to quiet the inflammatory process and restore tissue homeostasis.
ImmunologyOncology
Funding History
2Total raised:$69M
Series A$59MMar 15, 2021
Seed$10MJun 15, 2019